Bioprocessing

Bioprocessing uses a complete living cell, or their components, to obtain or create a desired pharmaceutical product. Recent scientific advancements have led to biopharmaceuticals being the fastest growing drug type, leading to rapid process and equipment advances. Below you can explore editorial articles, webinars, informational resources, and products curated to keep you up to date with bioprocessing advancements.

Editorial Articles

  • CAR-T-Similars: Will We See Future Biosimilar Versions of CAR-T Therapies?

    Since the first monoclonal antibody (mAb) drug was approved in 1986, more than 100 different mAbs have been approved by the U.S. FDA (Food and Drug Administration) and EMA (European Medicines Agency). During this period, manufacturing scaled up from an almost lab-like process to pharma-grade manufacturing with greater standardization and quality, ... read more

  • Customized Antibodies – Vehicles for Therapeutic Success

    They measure only a few nanometers in size, and yet they are our bodies’ first defense line against intruders of all kinds: antibodies are an integral part of our immune system. Since their discovery in the 1890s, science has made huge progress in understanding the mechanisms behind immunoglobulins. read more

  • Executive Q&A: Samsung Biologics

    Samsung Biologics continues to introduce new and innovative technology platforms with high-performing solutions that enhance therapeutic efficacy and proactively address evolving industry trends. S-AfuCHO™ is a cell line platform that can generate afucosylated antibodies that exhibit enhanced antibody-dependent cellular cytotoxity (ADCC) activity... read more
Page

Resources

Page

Webinars

  • <<
  • >>